TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34214220

Group type: EXPERIMENTAL
Intervention: Fractional radiofrequency microneedling + PRP (group A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fractional radiofrequency microneedling monotherapy (group B)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 20
Study: 33913638

Group type: EXPERIMENTAL
Intervention: Vadadustat
Number of subjects: 3923

Group type: COMPARATOR
Intervention: Darbepoetin alfa
Number of subjects: 3923
Study: 33221326

Group type: EXPERIMENTAL
Intervention: Abicipar 2 mg every 8 weeks (abicipar Q8, n=630)
Number of subjects: 1888

Group type: EXPERIMENTAL
Intervention: Abicipar 2 mg every 12 weeks (abicipar Q12, n=628)
Number of subjects: 1888

Group type: COMPARATOR
Intervention: Ranibizumab 0.5 mg every 4 weeks (ranibizumab Q4, n=630)
Number of subjects: 1888
Study: 33663225

Group type: EXPERIMENTAL
Intervention: Biventricular pacing
Number of subjects: 15

Group type: COMPARATOR
Intervention: Unpaced conduction
Number of subjects: 15
Study: 34767866

Group type: EXPERIMENTAL
Intervention: OC‐01 0.03 mg
Number of subjects: 758

Group type: EXPERIMENTAL
Intervention: OC‐01 0.06 mg
Number of subjects: 758

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 758

Group type: EXPERIMENTAL
Intervention: OC‐01
Number of subjects: 758
Study: 32598243

Group type: EXPERIMENTAL
Intervention: Single dose intravenous (i.v.) antibiotic
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotic + additional dose i.v. antibiotic
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Prophylaxis + additional dose i.v. antibiotic + oral antibiotic
Number of subjects: 114
Study: 34581196

Group type: EXPERIMENTAL
Intervention: PASTA (Posterior Arthroscopic Subtalar Arthrodesis)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Open subtalar arthrodesis
Number of subjects: 56
Study: 32928003

Group type: EXPERIMENTAL
Intervention: Tiotropium/Olodaterol
Number of subjects: 1596

Group type: COMPARATOR
Intervention: Tiotropium
Number of subjects: 1596
Study: 36173619

Group type: EXPERIMENTAL
Intervention: Stereotactic ablative body radiotherapy (SABR) to up to 5 metastases
Number of subjects: 381
Study: 33539750

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous infusion of pertuzumab and trastuzumab
Number of subjects: 0
Study: 32602170

Group type: EXPERIMENTAL
Intervention: Combination nicotine replacement therapy (cNRT)
Number of subjects: 1024

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 1024

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1024
Study: 35045735

Group type: EXPERIMENTAL
Intervention: 8 sessions of weekly, individualized, lifestyle education (diet and PA) with behavior change and social support delivered predominantly by telehealth.
Number of subjects: 22

Group type: COMPARATOR
Intervention: Usual care alone.
Number of subjects: 22
Study: 33284503

Group type: EXPERIMENTAL
Intervention: HeartWare or HeartMate III device
Number of subjects: 3434
Study: 35964671

Group type: EXPERIMENTAL
Intervention: Extreme cold weather (defined by cold day and cold wave definitions)
Number of subjects: 92119

Group type: EXPERIMENTAL
Intervention: Extreme cold weather (cold wave definitions)
Number of subjects: 92119

Group type: EXPERIMENTAL
Intervention: Extreme cold weather impact on women
Number of subjects: 92119
Study: 32869593

Group type: EXPERIMENTAL
Intervention: 50 μL bloodletting at tip of ear
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 100 μL bloodletting at tip of ear
Number of subjects: 108

Group type: COMPARATOR
Intervention: Western medication (levofloxacin eye drops and gel)
Number of subjects: 108
Study: 36080897

Group type: EXPERIMENTAL
Intervention: 100% vibrotactile feedback
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 33% vibrotactile feedback
Number of subjects: 12

Group type: COMPARATOR
Intervention: Unrelated vibrotactile feedback (sham condition)
Number of subjects: 12
Study: 33616545

Group type: EXPERIMENTAL
Intervention: MAT + A-CHESS
Number of subjects: 416

Group type: COMPARATOR
Intervention: MAT alone (control arm)
Number of subjects: 416
Study: 32881906

Group type: EXPERIMENTAL
Intervention: Young drivers (19-25 years)
Number of subjects: 1764

Group type: EXPERIMENTAL
Intervention: Old drivers (≥ 60 years)
Number of subjects: 1764

Group type: COMPARATOR
Intervention: Middle-aged drivers (26-59 years)
Number of subjects: 1764
Study: 36419153

Group type: EXPERIMENTAL
Intervention: 6-week cardiovascular rehabilitation (CVR) program
Number of subjects: 140

Group type: COMPARATOR
Intervention: usual care 6-month wait-list control group
Number of subjects: 140
Study: 34739194

Group type: EXPERIMENTAL
Intervention: Daprodustat (oral HIF-PHI)
Number of subjects: 2964

Group type: COMPARATOR
Intervention: Epoetin alfa (for hemodialysis) or darbepoetin alfa (for peritoneal dialysis) (injectable ESA)
Number of subjects: 2964

Group type: EXPERIMENTAL
Intervention: Daprodustat
Number of subjects: 2964

Group type: COMPARATOR
Intervention: Epoetin alfa or darbepoetin alfa
Number of subjects: 2964
Study: 34657223

Group type: EXPERIMENTAL
Intervention: ZnPc(Lys)5 (group B)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hydrogen peroxide (group C)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Physiological saline (group A)
Number of subjects: 12
Study: 33639993

Group type: EXPERIMENTAL
Intervention: Standardized patient instructors (SPIs) intervention with 3 visits over 3–6 months
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group with no intervention
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Standardized patient instructors (SPIs) intervention
Number of subjects: 55
Study: 32520654

Group type: EXPERIMENTAL
Intervention: Individualized active aging counseling intervention
Number of subjects: 204

Group type: COMPARATOR
Intervention: Control group (general health information)
Number of subjects: 204
Study: 35688056

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 89

Group type: COMPARATOR
Intervention: Physical exercise
Number of subjects: 89
Study: 33040811

Group type: EXPERIMENTAL
Intervention: Invisible orthodontic appliance with minocycline
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Self‐ligation orthodontic appliance with minocycline
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Traditional ligation bracket with minocycline
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: All groups with minocycline
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: All three orthodontic treatments
Number of subjects: 180
Study: 36201240

Group type: EXPERIMENTAL
Intervention: Nabilone (1-2 mg, oral)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: COMPARATOR
Intervention: Nabilone and Placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Nabilone
Number of subjects: 28
Study: 32212742

Group type: EXPERIMENTAL
Intervention: Specific prompts
Number of subjects: 315

Group type: COMPARATOR
Intervention: General prompts
Number of subjects: 315
Study: 35501744

Group type: EXPERIMENTAL
Intervention: MDRT + 6 months ADT
Number of subjects: 280

Group type: COMPARATOR
Intervention: MDRT alone
Number of subjects: 280
Study: 33730016

Group type: EXPERIMENTAL
Intervention: Kisumu hematology reference ranges
Number of subjects: 1509

Group type: EXPERIMENTAL
Intervention: Gender differences in hematological values
Number of subjects: 1509

Group type: EXPERIMENTAL
Intervention: Gender differences across all age groups
Number of subjects: 1509
Study: 36401488

Group type: EXPERIMENTAL
Intervention: Stabilization exercise program using respiratory resistance (SER)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Stabilization exercise program using respiratory resistance and whole body vibration (SERW)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Stabilization exercise (SE)
Number of subjects: 48
Study: 33727311

Group type: EXPERIMENTAL
Intervention: Escalation of therapy in 94 patients
Number of subjects: 1903

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 1903
Study: 36175997

Group type: EXPERIMENTAL
Intervention: green‐MED diet (100 g frozen cubes/day of Wolffia globosa, 3-4 cups/day of green tea, 28 g/day of walnuts)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: MED diet (28 g/day of walnuts)
Number of subjects: 294

Group type: COMPARATOR
Intervention: healthy dietary guidelines (HDG)
Number of subjects: 294
Study: 33389797

Group type: EXPERIMENTAL
Intervention: Lorcaserin (10 mg BID)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 32228720

Group type: EXPERIMENTAL
Intervention: Internal TCM treatment for mild-to-moderate plaque psoriasis
Number of subjects: 378

Group type: COMPARATOR
Intervention: External TCM treatment for mild-to-moderate plaque psoriasis
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: TCM treatment for severe plaque psoriasis
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: WM treatment for severe plaque psoriasis
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: TCM + WM treatment for severe plaque psoriasis
Number of subjects: 378

Group type: COMPARATOR
Intervention: All groups (TCM, WM, TCM + WM)
Number of subjects: 378
Study: 36412412

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol 400 mcg given 3 hours prior to the procedure
Number of subjects: 36

Group type: COMPARATOR
Intervention: No misoprostol (control group)
Number of subjects: 36
Study: 32178337

Group type: EXPERIMENTAL
Intervention: 30-min High-Intensity Intermittent Exercise (HIIE)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 60-min High-Intensity Intermittent Exercise (HIIE)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Resting condition
Number of subjects: 39
Study: 35225112

Group type: COMPARATOR
Intervention: Therapeutic lumbar puncture (LP)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Therapeutic lumbar drainage (LD)
Number of subjects: 116
Study: 32391881

Group type: EXPERIMENTAL
Intervention: Adjunctive oral cannabidiol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35264510

Group type: EXPERIMENTAL
Intervention: Palatal brushing and standard oral/denture hygiene
Number of subjects: 77

Group type: COMPARATOR
Intervention: Standard oral/denture hygiene instructions only
Number of subjects: 77
Study: 32964717

Group type: EXPERIMENTAL
Intervention: Furosemide (0.2 to 0.5 mg/kg as a continuous intravenous infusion for 24 hours postoperatively)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control group (standard hydration regimen)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Furosemide combined with standard hydration therapy
Number of subjects: 230
Study: 32962709

Group type: EXPERIMENTAL
Intervention: CHF6001 400, 800, 1200 or 1600 μg twice daily (BID)
Number of subjects: 1130

Group type: EXPERIMENTAL
Intervention: CHF6001
Number of subjects: 1130

Group type: EXPERIMENTAL
Intervention: CHF6001 800 and 1600 μg BID
Number of subjects: 1130

Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 1130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1130
Study: 36036525

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 4531

Group type: COMPARATOR
Intervention: Vitamin K antagonist
Number of subjects: 4531
Study: 34936167

Group type: EXPERIMENTAL
Intervention: Vaporized cannabis containing 13.75 mg THC
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 33309920

Group type: EXPERIMENTAL
Intervention: Self-navigated 3D whole-heart MRA
Number of subjects: 20

Group type: COMPARATOR
Intervention: Contrast-enhanced CTA
Number of subjects: 20
Study: 32115392

Group type: EXPERIMENTAL
Intervention: Clinical pharmacist support
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Medication education and management
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Non‐medication‐related patient education
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Care coordination
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Miscommunication related to scheduling
Number of subjects: 244
Study: 35248290

Group type: EXPERIMENTAL
Intervention: Spinal mobilisation intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 40
Study: 33459183

Group type: EXPERIMENTAL
Intervention: Adaptive design integrating dose finding and confirmation steps
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Response adaptive randomization, sample size modification, and multiple testing techniques
Number of subjects: 0
Study: 33761716

Group type: EXPERIMENTAL
Intervention: Peri-induction warming using a forced-air warmer set at 47°C
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group covered passively with a cotton blanket
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Peri-induction warming
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Peri-induction warming and Control group
Number of subjects: 130
Study: 36152053

Group type: EXPERIMENTAL
Intervention: Painful electrical shock paired with words
Number of subjects: 25

Group type: COMPARATOR
Intervention: Non-pain associated words
Number of subjects: 25
Study: 32712388

Group type: EXPERIMENTAL
Intervention: Dominant side CVAD insertion
Number of subjects: 640

Group type: COMPARATOR
Intervention: Non-dominant side CVAD insertion
Number of subjects: 640
Study: 35790981

Group type: EXPERIMENTAL
Intervention: Fee-for-service (FFS)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Diagnosis-Related Group (DRG)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Mixed payment schemes (including two FFS-based and three DRG-based)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Higher disease severity
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Lower disease severity
Number of subjects: 210
Study: 33928908

Group type: EXPERIMENTAL
Intervention: Kundalini yoga
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sleep hygiene
Number of subjects: 40
Study: 35038027

Group type: EXPERIMENTAL
Intervention: Endoscopic modified cartilage over‐underlay myringoplasty with packing (n=35)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Endoscopic modified cartilage over‐underlay myringoplasty without packing (n=35)
Number of subjects: 70
Study: 34559230

Group type: EXPERIMENTAL
Intervention: 300 mg of FRM-0334
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 500 mg of FRM-0334
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: FRM-0334 (both doses)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Bifrontal FDG-PET
Number of subjects: 27
Study: 34985771

Group type: EXPERIMENTAL
Intervention: Online intervention supporting couples' posttreatment recovery of sexual intimacy, comprising 6 modules addressing expectations for sexual and emotional sequelae of treatment, rehabilitation, and guidance toward sexual intimacy recovery.
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Online intervention supporting couples' posttreatment recovery of sexual intimacy.
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 142
Study: 32783330

Group type: EXPERIMENTAL
Intervention: Topical PR gel under the left orbit once a day and topical plus nano‐microneedle‐assisted PR gel under the right orbit twice a week
Number of subjects: 20

Group type: COMPARATOR
Intervention: Gel without PR (Control)
Number of subjects: 20
Study: 34427049

Group type: EXPERIMENTAL
Intervention: ASP5354 0.1 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: ASP5354 (0.1 mg to 24 mg)
Number of subjects: 6
Study: 33484515

Group type: EXPERIMENTAL
Intervention: Core stability exercises along with traditional therapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Traditional low backache physical therapy
Number of subjects: 24
Study: 34817871

Group type: EXPERIMENTAL
Intervention: Abstinence from gaming for 7 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no abstinence)
Number of subjects: 50
Study: 33242498

Group type: EXPERIMENTAL
Intervention: Deficit-trained patients
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sighted-trained patients
Number of subjects: 48
Study: 36250505

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AET)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Stretching-and-toning (SAT, active control)
Number of subjects: 73
Study: 33517744

Group type: EXPERIMENTAL
Intervention: Basic articulation + liuzijue qigong (48 patients)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Basic articulation + traditional breathing training (50 patients)
Number of subjects: 98
Study: 34138468

Group type: EXPERIMENTAL
Intervention: Intravenous polyspecific immunoglobulin G (IVIG) 25 g/d for 3 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 36376474

Group type: EXPERIMENTAL
Intervention: H. pylori eradication treatment
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study: 32578261

Group type: EXPERIMENTAL
Intervention: Social story-based intervention
Number of subjects: 306

Group type: COMPARATOR
Intervention: Standard leaflets (Control)
Number of subjects: 306
Study: 34159507

Group type: EXPERIMENTAL
Intervention: FCU4Health
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 240
Study: 33225782

Group type: EXPERIMENTAL
Intervention: Isosorbide‐5‐mononitrate capsule
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35965813

Group type: EXPERIMENTAL
Intervention: Zengxiao Jiandu decoction combined with definitive concurrent chemoradiotherapy (DCCRT)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Control arm (DCCRT alone)
Number of subjects: 163
Study: 36073985

Group type: EXPERIMENTAL
Intervention: Fixed lists of concrete words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized lists of concrete words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fixed lists of abstract words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized lists of abstract words
Number of subjects: 0
Study: 32561468

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (40 IU) administered prior to each PE therapy session
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo administered prior to each PE therapy session
Number of subjects: 0
Study: 36421994

Group type: EXPERIMENTAL
Intervention: Whole Phaeodactylum tricornutum (PT)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: β‐1,3‐glucan‐rich PT supernatant (SupB)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Combination of Whole PT and SupB (A+SupB)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Comparator product (Comp)
Number of subjects: 19
Study: 33210309

Group type: EXPERIMENTAL
Intervention: Haemostasis Traffic Light
Number of subjects: 84

Group type: COMPARATOR
Intervention: Text-based algorithm
Number of subjects: 84
Study: 32220355

Group type: EXPERIMENTAL
Intervention: Curcumin 500 mg/day for 12 weeks
Number of subjects: 60
Study: 35144238

Group type: EXPERIMENTAL
Intervention: 8-week motivational interviewing and cognitive-behavioral intervention delivered in secret Facebook groups by electronic health coaches (e-coaches)
Number of subjects: 149

Group type: COMPARATOR
Intervention: 8-week attention-placebo control condition
Number of subjects: 149
Study: 33729546

Group type: EXPERIMENTAL
Intervention: FOLFOX (all three agents)
Number of subjects: 2246

Group type: COMPARATOR
Intervention: 5‐FU/LV (only 5‐fluorouracil and leucovorin)
Number of subjects: 2246
Study: 33957160

Group type: EXPERIMENTAL
Intervention: Classical olfactory training (OT) with 4 fixed odors
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Modified olfactory training (OT) with 4 sets of 4 different odors sequentially
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 25
Study: 33666561

Group type: EXPERIMENTAL
Intervention: Self-affirmation induction upon study entry
Number of subjects: 7899

Group type: EXPERIMENTAL
Intervention: Self-affirming text notifications during quit attempt
Number of subjects: 7899

Group type: EXPERIMENTAL
Intervention: Spontaneous self-affirmation
Number of subjects: 7899

Group type: EXPERIMENTAL
Intervention: Baseline sadness
Number of subjects: 7899

Group type: EXPERIMENTAL
Intervention: Optimism
Number of subjects: 7899

Group type: EXPERIMENTAL
Intervention: Happiness and anger
Number of subjects: 7899

Group type: COMPARATOR
Intervention: Conventional notifications
Number of subjects: 7899
Study: 35102971

Group type: COMPARATOR
Intervention: Formocresol pulpotomy
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Laser photobiomodulation pulpotomy
Number of subjects: 68
Study: 34126156

Group type: EXPERIMENTAL
Intervention: REGN5713/14/15 (900 mg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 33394214

Group type: EXPERIMENTAL
Intervention: Lansoprazole (LAN) 60 mg p.o. bid for one week before starting each cycle + R‐CHOP
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Famotidine (FAM) 40 mg p.o. once daily one week before cycle and continues daily through the cycle + R‐CHOP for six cycles
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group received R‐CHOP standard chemotherapy
Number of subjects: 60
Study: 35690876

Group type: EXPERIMENTAL
Intervention: Exergaming intervention (12-week program, three 30-min sessions per week using Xbox Kinect activity-based games)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine treatment (standard model of care delivered by the Justice Health and Forensic Mental Health Network)
Number of subjects: 0
Study: 32646967

Group type: EXPERIMENTAL
Intervention: Self-reported physical activity
Number of subjects: 377234

Group type: EXPERIMENTAL
Intervention: Accelerometer-measured physical activity
Number of subjects: 377234

Group type: EXPERIMENTAL
Intervention: Histologic types of lung cancer
Number of subjects: 377234
Study: 35501170

Group type: EXPERIMENTAL
Intervention: Metabolic syndrome (MetS) present in patients with T1DM
Number of subjects: 978

Group type: EXPERIMENTAL
Intervention: Elevated waist circumference in patients with MetS
Number of subjects: 978
Study: 34050701

Group type: EXPERIMENTAL
Intervention: Real 1-Hz rTMS (30 min/day for 14 days)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sham 1-Hz rTMS (30 min/day for 14 days)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Real 1-Hz rTMS
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sham 1-Hz rTMS
Number of subjects: 37
Study: 32267847

Group type: EXPERIMENTAL
Intervention: First-line antiretroviral therapy
Number of subjects: 31